Regulation of the cutaneous circulation

In this symposium, a diversity of perspectives was focused on how blood flow to the skin is controlled. Thus, control of the cutaneous circulation by reflexes aimed at body temperature regulation, blood pressure regulation, and the reflexes attending muscular exercise was discussed in detail, as were the similarities and differences between control of cutaneous arterioles and arteriovenous anastomoses. A mechanistic treatment of interaction between adrenergic control of cutaneous blood vessels and their temperature brought physical factors and pharmacological approaches to the consideration of reflex control. Finally, the more slowly developing changes in the control of the skin circulation that accompany circadian rhythms, changes in blood volume or its distribution, physical training, and acclimatization were discussed. Because the cutaneous circulation has potentially large vascular conductance, blood flow, and blood volume, control of the resistance and compliance vessels within the skin has an importance well beyond that of tissue nutrition. Indeed, overall hemodynamics are dependent on how much blood flow and how much blood volume are distributed to skin. Consequently, reflex factors, physical factors, and their interaction all have roles of importance with respect to exchange of heat with environment as well as maintenance of blood pressure, cardiac output, and blood flow to other tissues.     

Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy

The lysosomal degradation of sulfatide requires the specific enzyme, arylsulfatase A, as well as a heat stable protein called sphingolipid activator protein-1 (SAP-1). While most patients with metachromatic leukodystrophy have defects in arylsulfatase A, some patients have defects in SAP-1. SAP-1 is coded for by a gene on human chromosome 10 that also codes for three other proposed SAP. Examination of the cDNA from two siblings with SAP-1 deficiency revealed a point mutation of nucleotide #650 (counting from the initiation ATG) which is in the SAP-1 coding domain. This C to T transition changed the codon from threonine (ACC) to one coding for isoleucine (ATC). This eliminated the only glycosylation site in mature SAP-1 and could explain the findings made at the protein level.     

Comparison of cold enrichment and U.S. Department of Agriculture methods for isolating Listeria monocytogenes from naturally contaminated foods. The Listeria Study Group.

We compared the cold enrichment (CE) and U.S. Department of Agriculture (USDA) methods for isolating Listeria monocytogenes by examining 402 food samples. The food samples were collected from refrigerators of listeriosis patients as part of a multistate active surveillance project to determine the role of foods in sporadic listeriosis in the United States. L. monocytogenes was isolated from 51 food samples (13%). The USDA method was significantly better (P less than 0.001) than the CE method. The isolation efficiencies of the USDA and CE methods were 96 and 59%, respectively. Quantitation of L. monocytogenes in the food samples revealed that many food samples containing less than 0.3 CFU/g were negative as determined by the CE method but positive as determined by the USDA method.     

Informal Workshop on Potential Regulatory and Licensing Issues for Pneumococcal Conjugate Vaccines

(1) It is likely that a seven-valent pneumococcal conjugate vaccine will be licensed in the next few years based on efficacy studies. Licensure of nine- or 11-valent vaccines will be sought soon thereafter. Further studies of nine- or 11-valent vaccines which can evaluate efficacy of the added serotypes will be unlikely. (2) Licensure of other vaccines (including those with additional serotypes), will depend on evaluation of surrogates for efficacy. (3) The most accepted surrogate of efficacy at this point is some combination of functional assay (e.g. opsonophagocytosis), and/or serology of anticapsular antibody by ELISA or RIA that correlates closely with the functional test. (4) An additional important correlate of immunity for polysaccharide conjugate vaccines may be measurement of the booster response. (5) Although effect on nasopharyngeal carriage may be developed into a useful correlate of efficacy in the future, much additional work must be done before carriage data can be interpreted usefully for this purpose. (6) Testing for consistency of production of pneumococcal conjugate vaccines will follow lines similar to that for Hib conjugate vaccines. Thus, instead of one set of universally applicable lot release criteria, vaccine-specific criteria must be developed collaboratively between industry and national control authorities.     

Deficiency of monogalactosyl diglycerid beta-B-galactosidase activity in krabbe's disease

Monogalactosyl diglyceride has previously been demonstrated to be intimately associated with brain white matter, especially myelin. Enzymes responsible for its biosynthesis and degradation have been reported to be present in rat and mouse brain. In the present study, the β-galactosidase responsible for the degradation of this brain specific compound was demonstrated to be extremely deficient in brain, liver and skin fibroblasts from patients who died of Krabbe's disease. This deficiency is the third enzymatic block demonstrated in this disorder. The β-galactosidase activity toward galactocerebroside and psychosine is also extremely deficient. This finding provides new information about the substrate recognition pattern of this enzyme and about the possible etiology of globoid cell leukodystrophy.